Ardelyx, Inc.

ARDX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013
Assets
Cash & Equivalents $75.4M $74.6M $107.0M $107.3M $34.4M
Accounts Receivable — — — $2.6M $6.4M
Inventory — — — — —
Total Current Assets $149.7M $204.0M $112.0M $111.1M $41.8M
Property, Plant & Equipment $8.0M $9.0M $4.7M $2.1M $530.0K
Goodwill — — — — —
Intangible Assets (Excl. Goodwill) — — — — —
Total Assets $157.9M $213.1M $116.9M $113.4M $42.9M
Liabilities
Accounts Payable $3.9M $5.6M $2.8M $3.1M $2.3M
Total Current Liabilities $17.9M $19.2M $7.7M $21.5M $17.1M
Long-Term Debt — — — — —
Total Liabilities $18.6M $20.0M $8.0M $52.7M $50.2M
Stockholders' Equity
Retained Earnings $-278.2M $-213.9M $-101.5M $-71.9M $-68.7M
Total Stockholders' Equity $139.3M $193.2M $108.9M $60.7M $-63.5M
← Newer Page 2 of 2 Older →